Our research teams have made significant basic science contributions to the study of infectious disease-causing organisms and are paving the way for new therapies.
The Jacobs School of Medicine and Biomedical Sciences jumped four spots in the annual ranking of medical school research funding received from the National Institutes of Health (NIH), according to data compiled by the Blue Ridge Institute for Medical Research.
Twelve Jacobs School of Medicine and Biomedical Sciences faculty members have received funding through the Undergraduate Research and Creative Activities Program for projects starting in January 2026.
The Jacobs School of Medicine and Biomedical Sciences has been awarded a T32 training grant from the National Institutes of Health to train more cellular, biochemical and molecular scientists.
Ryan Hunter, PhD, associate professor of microbiology and immunology, recently created a device to study anaerobic bacteria alongside oxygenated cells, simulating microenvironments within the body.
Impact of polymicrobial interactions and within-host adaptation on CAUTI pathogenesis. Chelsie Armbruster (Principal Investigator). NIDDK. $3,693,751. 7/1/2025-6/1/2030.
The urothelial glycosaminoglycan layer: composition and contribution to pathogen fitness during catheter-associated urinary tract infection. Chelsie Armbruster (Principal Investigator). NIH/NIDDK. $3,045,103. 6/1/2024-4/1/2029.
Virologic and immunologic impacts of active viral persistence in lung AMs of HIV-1-infected, cART-suppressed individuals. Saikat Boliar (Principal Investigator). NIAID. $2,915,905. 5/1/2024-3/1/2029.